Term Name: lenvatinib mesylate
Synonyms: 6-carbamoyl-4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinolin-1-ium methanesulfonate, E7080, Lenvatinib mesilate, Lenvima, methanesulfonic acid--4-{3-chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxyquinoline-6-carboxamide (1/1), N-(4-((6-Carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)-N'-cyclopropylurea monomethanesulfonate, UNII-3J78384F61
Definition: A methanesulfonate salt obtained by reaction of lenvatinib with one molar equivalent of methanesulfonic acid. A multi-kinase inhibitor and orphan drug used (as its mesylate salt) for the treatment of various types of thyroid cancer that do not respond to radioiodine.
Ontology: ChEBI [CHEBI:85995]  ( EBI )

Relationships
is a type of: methanesulfonate salt
has_part: lenvatinib(1+)
has_role: antineoplastic agent EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor fibroblast growth factor receptor antagonist orphan drug vascular endothelial growth factor receptor antagonist